Iroquois Capital Management LLC 13D and 13G filings for MyMD Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 11:27 am Purchase | 2023-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD | Iroquois Capital Management LLC | 168,853 4.990% | 109,815 (+186.01%) | Filing |
| 2023-02-14 07:40 am Sale | 2022-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD | Iroquois Capital Management LLC | 59,038 6.470% | -13,582 (-18.70%) | Filing |
| 2022-02-23 4:45 pm Purchase | 2021-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD | Iroquois Capital Management LLC | 72,620 9.560% | 72,620 (New Position) | Filing |